Showing 2511-2520 of 9456 results for "".
EXELO2 by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/exelo2-by-quantel-derma/19448/EXELO2 by Quantel Derma is a versatile laser system for fractional treatments and full ablation for the treatment of wrinkles and scars. Shape and size of the treatment area can be set directly at the scanner hand-piece. EXCELO2 offers Random Scanning for better aesthetic results and Full Ablation MKelly on CoolSculpting
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/kelly-on-coolsculpting/19462/Watch to hear Kelly discuss results of the CoolSculpting procedure he had done to his abdomen.Sciton Resurfacing Laser Technologies - Patient Testimonials
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/sciton-resurfacing-laser-technologies-patient-testimonials--michisug/19484/Sciton Laser Technology treatments include Deep Resurfacing, MicroLaserPeel, ProFractional Therapy, and Combination Treatments to stimulate collagen, correct superficial imperfections almost immediately, and improve skin's texture & tone in just 1-4 treatment sessions.Fighting for Coverage: Combatting Private Insurance to Get Patients the Drugs They Need
https://practicaldermatology.com/issues/july-2025/fighting-for-coverage/36503/Aside from decreasing reimbursement rates, obtaining prior authorization from private insurance for medications that our patients desperately need to improve their lives, improve their skin conditions, and improve their wellbeing is probably the greatest challenge that dermatologists face today.Telephone Mystery Shopping and Converting New Patients
https://practicaldermatology.com/issues/april-2025/telephone-mystery-shopping-and-converting-new-patients/35621/Even with today’s market focused on online digital marketing, a practice’s biggest revenue source opportunity still seems to be the phones. The first interaction most new patients have with a practice is on the phone, which used to be about 99% of the time; now, we believe it is about 80%.Emrosi Launched in the US for Rosacea
https://practicaldermatology.com/series/dermwire-tv/emrosi-launched-in-the-us-for-rosacea/33943/In this week's DermwireTV, a new treatment for rosacea is launched in the US; long-term data is presented for tapinarof 1% cream for atopic dermatitis; and in our C-Suite Chats segment, we speak with the CEO and Co-Founder of Mama Sol.I Came In Like a Wrecking Ball
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/i-came-in-like-a-wrecking-ball/33162/I have to start by warning you, dear reader, that I am writing my first editorial for Practical Dermatology immediately after typing up four appeal letters to insurance companies.ISDPA: Dr. Lal on Therapeutic Updates
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-lal-therapeutic-updates/29149/Karan Lal, DO, discusses the latest therapeutic updates for atopic dermatitis and other conditions, including his strategies for utilizing dupilumab, at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.Why is CSF Different?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/why-is-csf-different/20124/Discover why CSF is different from other meetings. Attendees and faculty share their CSF experience and describe why they think the meeting and its new Nashville home make for “a great program.”Multidimensional Impact of Prurigo Nodularis
https://practicaldermatology.com/topics/atopic-dermatitis/multidimensional-impact-of-prurigo-nodularis/20048/Like most dermatologists, you may find it challenging to keep up with the rapid discoveries regarding inflammatory skin diseases and new developments in treatment. This informational webinar will provide updates on evolving areas of practice.